Updates on Clinical Trials in Oncology and Radiation

Availability

On-Demand

Access expires on 06/13/2025

Credit Offered

1.25 CME / CE Credits

1.25 MOC Points

1.25 RN Credits

1.25 PA Credits

1.25 Sleep CME Credits

Two internationally known medical and radiation oncologists will discuss ongoing and recent clinical trials and offer their perspectives on how they will impact thoracic oncology practice. The panelists will also discuss current guidelines for managing patients with advanced lung cancer and emphasize the role of tissue and blood biomarkers.

Objectives:
At the end of this webinar, the learners will be able to:

Address barriers to treatment such as patient comorbidities and therapy side effects
Diagnose and manage patients with advanced non-small cell lung cancer (NSCLC) according to the latest NCCN, ASCO, ASTRO, IASLC, and CHEST guidelines
Explain the role of plasma-based cell-free circulating tumor DNA next generation sequencing (NGS) testing for managing advanced NSCLC at the time of diagnosis and disease progression
Review the results of recent trials in medical and radiation oncology

Program made possible in part by an independent educational grant from AstraZeneca Pharmaceuticals, an educational grant from Genentech, a member of the Roche Group, and an independent medical education grant from Merck Sharp & Dohme Corp.

As of November 2023, MOC points will be claimed separately from CME credit and submitted instantaneously. Learners will be required to enter their date of birth and American Board of Internal Medicine ID numbers when claiming MOC points.